MoneyWorks4Me

Aurobindo Pharma informs about disclosure

17 Mar 2020 Evaluate

Aurobindo Pharma has informed that the exchange has received disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 17, 2020 for K Nityananda Reddy.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1752.50
Dr. Reddys Labs. 1180.00
Cipla 1305.00
Lupin 1942.00
Zydus Lifesciences 1115.20
View more..